黄酮类化合物是一大类天然存在的有机化合物,属于酚类衍生物。它们的分子结构通常包含两个苯环(A和B环)和一个三碳环(C环),形成一个基本骨架。该骨架由多个亚结构组成,包括黄烷醇、黄酮、黄酮醇等。
生物来源黄酮类化合物广泛存在于植物界中,常见于许多蔬菜、水果及中药中。例如,在大豆、柑橘、茶叶和甘草中都可以找到它们的身影。
化学性质 亲水性与溶解度由于其分子结构中含有多个酚羟基,因此具有一定的亲水性和良好的溶解性,这使得黄酮类化合物在药物设计中扮演重要角色。
稳定性与光敏性大多数黄酮类化合物相对稳定,在适宜条件下不易发生降解。但某些类型的黄酮对光照比较敏感,容易被氧化,导致颜色变化。
生理活性与药用价值黄酮类化合物因其丰富的生理活性而备受关注,主要包括:
作为一种天然色素和抗氧化剂,被广泛应用于食品加工中以提高其保质期及营养价值。
化妆品行业利用其良好的生物相容性和抗衰老特性,在化妆品配方中应用广泛。
药物开发由于黄酮类化合物展现出广泛的药理活性,已成为新药研发的重要候选目标之一。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | 2-(4-Chlorophenyl)-6,7-dimethyl-4H-chromen-4-one | 89112-91-4 | C17H13ClO2 |
|
—— | 6,8-dichloro-2-(2-methoxy-phenyl)-chromen-4-one | 89112-87-8 | C16H10Cl2O3 |
|
—— | 6,8-Dichloro-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one | 80972-96-9 | C16H10Cl2O3 |
|
—— | 2-(4-Chlorophenyl)-6,8-dimethyl-4H-1-benzopyran-4-one | 89112-90-3 | C17H13ClO2 |
|
—— | 3-(4-phenoxybutoxy)-2-phenyl-4H-[1]benzopyran-4-one | 1158849-48-9 | C25H22O4 |
|
—— | 3,6-dichloro-2-(4-fluorophenyl)-7-methyl-4H-chromen-4-one | 1260668-02-7 | C16H9Cl2FO2 |
|
—— | (2S)-6-chloro-2-(4-chlorophenyl)-2H-chromene | 1261361-64-1 | C15H10Cl2O |
|
—— | (2-(4-chloro-phenyl)-3-nitro-chroman-4-yl)-acetaldehyde | 1134455-47-2 | C17H14ClNO4 |
|
—— | 8-bromo-4',5,7-trimethoxyflavone | 35095-45-5 | C18H15BrO5 |
|
—— | diethyl 7-methoxy-3,4-diphenyl-3a-nitrobenzopyrano[3.4-c]pyrrolidine-1,1-dicarboxylate | 1227402-19-8 | C30H30N2O8 |
|
—— | (S)-7-methoxy-2-phenyl-3-nitro-2H-chromene | 1132763-87-1 | C16H13NO4 |
|
—— | (R)-7-methoxy-2-phenyl-3-nitro-2H-chromene | 1162662-43-2 | C16H13NO4 |
|
—— | 6,8-Difluoro-2-(3-fluoro-4-pivaloylaminophenyl)-5-pivaloylamino-4H-1-benzopyran-4-one | 152835-71-7 | C25H25F3N2O4 |
|
—— | 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-4H-1-benzopyran-4-one | 152169-56-7 | C15H9F3N2O2 |
|
—— | 6-Chloro-7-methyl-2-phenyl-2,3-dihydrochromen-4-one | 147919-55-9 | C16H13ClO2 |
|
—— | 2-(2-methoxyphenyl)-6-methoxy-3-nitro-2H-chromene | 57543-98-3 | C17H15NO5 |
|
—— | methyl 4-oxo-2-phenyl-4H-chromene-7-carboxylate | 40052-87-7 | C17H12O4 |
|
—— | 2-(4-(2-fluoroethoxy)-3-(methoxymethoxy)phenyl)-3,7-bis(methoxymethoxy)-4H-chromen-4-one | 1181377-20-7 | C23H25FO9 |
|
—— | (2R,3S,4R)-2,3-trans-3,4-trans-3,3',4',7-tetrahydroxy-4-<(2R,3S)-2,3-trans-3,3',4',7-tetrahydroxyflavan-6-yl>flavan | 78139-48-7 | C30H26O10 |
|
—— | (-)-fisetinidol-(4b,6)-(-)-robinetinidol | 117479-74-0 | C30H26O11 |
|
—— | (2R,3S,4S)-2,3-trans-3,4-cis-3,3',4',7-tetrahydroxy-4-<(2S,3S)-2,3-trans-3,3',4',7-tetrahydroxyflavan-6-yl>flavan | 78185-31-6 | C30H26O10 |
|
—— | 4-(2H-chromen-2-yl)-N,N-dimethylbenzenamine | 33871-82-8 | C17H17NO |
|
—— | (4R,5S,6S,10R,11S,12S,16R,17S)-6,12-bis(2,4-dihydroxyphenyl)-4,10,16-tris(3,4-dihydroxyphenyl)-3,9,15-trioxatetracyclo[12.4.0.02,7.08,13]octadeca-1(14),2(7),8(13)-triene-5,11,17-triol | 102258-24-2 | C45H38O16 |
|
—— | (2R,3S,4R)-2,3-trans-3,4-trans-3,3',4',7-tetrahydroxy-4-<(2S,3S)-2,3-cis-3,3',4',7-tetrahydroxyflavan-6-yl>flavan | 78185-29-2 | C30H26O10 |
|
—— | (+)-2,3-trans-3,4-cis:2,3-trans-3,4-cis-<4,6>-(-)-fisetinidol-(+)-leucofisetinidin | 81600-39-7 | C30H26O11 |
|
—— | (2R,3S,4S,8R,9S)-4-(2,4-dihydroxyphenyl)-2,8-bis(3,4-dihydroxyphenyl)-6-[(2R,3S,4S)-2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-3,4-dihydro-2H-chromen-4-yl]-2,3,4,8,9,10-hexahydropyrano[2,3-h]chromene-3,5,9-triol | 127612-67-3 | C45H38O16 |
|
—— | fisetinidol-(4β→8)-epicatechin | 78306-10-2 | C30H26O11 |
|
—— | (-)-Fisetinidol-(4β,4)-resorcinol | 69082-79-7 | C21H18O7 |
|
—— | (-)-fisetidinol-(4β,8)-(+)-catechin-O-methyl ether | 119065-89-3 | C31H28O11 |
|
—— | (+)-2,3-trans-3,4-cis:2,3-trans-3,4-trans-<4,6>-(-)-fisetinidol-(+)-leucofisetinidin | 20254-30-2 | C30H26O11 |
|
—— | (4α,6:4α,8)-bis-(-)-fisetinidol-(+)-catechin 4-O(E)-methyl ether | 127612-66-2 | C46H40O16 |
|
—— | (2R,3S,4R)-2,3-trans-3,4-cis-3-acetoxy-3',4',7-trimethoxy-4-(2,4,6-trimethoxyphenyl)flavan | 78340-80-4 | C29H32O9 |
|
—— | (2R,3S,4S)-2,3-trans-3,4-cis-3,3',4',7-tetrahydroxy-4-<(2R,3S)-2,3-trans-3,3',4',7-tetrahydroxyflavan-6-yl>flavan | 78139-48-7 | C30H26O10 |
|
—— | <4,6:4,6>-2,3-trans-3,4-cis:2',3'-trans-3',4'-trans:2'',3''-trans-3'',4''-bi-<(-)-fisetinidol>-(+)-mollisacacidin | 81557-53-1 | C45H38O16 |
|
—— | (2R,3S,4R)-3-acetoxy-4-<(2R,3S)-3-acetoxy-3',4',7-trimethoxyflavan-6-yl>-3',4',7-trimethoxyflavan | 78139-50-1 | C40H42O12 |
|
—— | (-)<(2R,3S)-2,3-trans-flavan-3,3',4',5',7-pentaol> | 528-56-3 | C15H14O6 |
|
—— | 8,9-cis-9,10-trans-tetrahydro-2H,8H-pyrano<2,3-h>chromane | 119067-92-4 | C31H28O11 |
|
—— | (2R,3S,4S)-2,3-trans-3,4-trans-3,3',4',7-tetrahydroxy-4-<(2R,3R)-2,3-cis-3,3',4',5,7-pentahydroxyflavan-8-yl>flavan | 78306-08-8 | C30H26O11 |
|
—— | (-)-epigallocatechin 3-O-p-coumaroate | 89013-65-0 | C24H20O9 |
|
—— | 2-(o-tolyl)-4H-chromen-4-one | 116115-49-2 | C16H12O2 |
|
—— | (+)-(2S,3S)-5,7-bis(benzyloxy)-2-[3,4-bis(benzyloxy)phenyl]chroman-3-yl 3,4,5-tris(benzyloxy)benzoate | 732298-16-7 | C71H60O10 |
|
—— | epigallocatechin-3-O-p-hydroxybenzoate-(4β->8)-epigallocatechin | 1359849-47-0 | C37H30O16 |
|
—— | gambirflavan D1 | 1005406-09-6 | C30H26O11 |
|
—— | gambiriin B1 | 76250-47-0 | C30H26O11 |
|
—— | (-)-epigallocatechin (2α,3α) | 136892-45-0 | C15H14O7 |
|
—— | [2,3-bis(2,2-dimethylpropanoyloxy)-5-[(2R,3S)-3-hydroxy-5,7-bis(phenylmethoxy)-3,4-dihydro-2H-chromen-2-yl]phenyl] 2,2-dimethylpropanoate | 1449477-26-2 | C44H50O10 |
|
—— | gallocatechin-(4α->6)-epigallocatechin | 135821-63-5 | C30H26O14 |
|
—— | theanaphthoquinone | 302776-47-2 | C28H22O11 |
|
—— | epigallocatechin hexaacetate | 21731-10-2 | C27H26O13 |
|
—— | (2R,3R)-4-deuterio-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol | 1200834-72-5 | C15H14O6 |
|